OBR Daily Commentary - Breast

forumImage

Sorry About Your Stage 3 Cancer. Here's A Bill For $21,000 In Charges You Thought Were Covered

(Los Angeles Times) Aug 7, 2018 - When Michele Brough was diagnosed with Stage 3 breast cancer in April, her oncologist wasted no time in reaching out to her insurer, Anthem Blue Cross and Blue Shield, to obtain pre-approval for a drug that would strengthen her immune system to better withstand chemotherapy.

Winston Wong, PharmD (Posted: August 13, 2018)

quotesUnfortunately, stories and reports like these are all too common. I have to wonder as I read this. Was the misfortune due to the mis-interpretation of Neulasta Onpro vs. Neupogen? The majority of Neulata is under the medical benefit. I can see the Neupogen being forced through specialty and self-administered. Nevertheless, the timing for responses was poor.quotes

Read Article arrow
Add Comment 1 Comment
forumImage

Complementary Medicine For Cancer Can Decrease Survival

(Yale News) July 19, 2018 - People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) at Yale School of Medicine. The findings were reported today online in JAMA Oncology. Use of complementary medicine — medical therapies that fall beyond the scope of scientific medicine — is growing in the United States and often used by patients with cancer.

H. Jack West, MD (Posted: July 20, 2018)

quotesVery unfortunate and very believable. Some proponents of complementary medicine note that "complementary" is intended to mean that these treatments are given alongside conventional therapies, rather than instead of them, as "alternative" medicines will be. Nevertheless, this work strongly indicts treatment philosophies that are not grounded in clinical evidence and shows that they clearly subtract more than they add for patients with treatable cancers, who are all too often presume that the "medicine" in complementary medicine is actually effective. That is the greater misnomer here, and it leads to net harm to the people gullible enough to pursue it.quotes

Read Article arrow
Add Comment 1 Comment
forumImage

First Opinion: Opioid Stigma Is Keeping Many Cancer Patients From Getting The Pain Control They Need

(STAT) July 6, 2018 - History is repeating itself. Twenty years ago, a pain management crisis existed. As many as 70 percent of cancer patients in treatment at that time, or in end-of-life care, experienced unalleviated pain.

Richard Reililng (Posted: July 07, 2018)

quotesCan't imagine that anyone would find this a surprise. Patients needing pain relief will suffer because of the weak personalities that take narcotics unnecessarily and for less than appropriate reasons. We have tried to fight this in many arenas including the AMA, but the 'bleeding hearts' win the field all the time. Let's hope that our cancer patients get what they need, when they need it, and in the quantity that makes their lives more tolerable in view of their disease processes. quotes

Read Article arrow
Add Comment 1 Comment

Meet the Editorial Board

Prostate Cancer
member photo
Tomasz M. Beer, MD, FACP

Professor of Medicine, Division of Hematology/Medical O...

Community Oncology
member photo
Dean Gesme, MD

FACP FACPE FASCO President, Minnesota Oncology...

Breast Cancer
member photo
Debu Tripathy, MD

Professor and Chair, Department of Breast Medical Oncol...

Lung Cancer
member photo
H. Jack West, MD

Medical Director, Thoracic Oncology Program, Swedish Ca...

Gastrointestinal Cancers
member photo
Howard S. Hochster, MD

Distinguished Professor of Medicine, Rutgers Robert Woo...

Radiation Oncology
member photo
Howard Sandler, MD, MS, FASTRO

Ronald H. Bloom Chair in Cancer Therapeutics
Pr...

Community Oncology
member photo
Jeff Patton, M.D.

CEO Tennessee Oncology...

Precision Medicine Section Editor
member photo
Jennifer Levin Carter, MD, MPH

Chief Medical Officer and Founder, N-of-One...

Financial Sector
member photo
Michael G. King Jr.

Managing Director and Senior Biotechnology Analyst...

Gastrointestinal Cancers
member photo
Richard Goldberg, MD

Director WVU Cancer Institute Director of Cancer Signa...

Editor-In-Chief
member photo
Robert A. Figlin, MD., FACP

Professor and Director, Division of Hematology Oncology...

Health Policy
member photo
Ted Okon

Executive Director Community Oncology Alliance...

Community Oncology
member photo
Thomas Marsland, MD

Vice President Integrated Community Oncology Network ...

Community Oncology
member photo
William Harwin MD

Florida Cancer Specialists President and Managing Part...

Health Policy
member photo
William McGivney, PhD

National Health Policy Expert...

Payer
member photo
Winston Wong, PharmD

President, W-Squared Group...